Inventor

GOTTELAND JEAN-PIERRE

FR23 patents

⚠️ This page may combine multiple inventors who share the name “GOTTELAND JEAN-PIERRE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GOTTELAND JEAN-PIERRE

SERONO LAB

Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein JunKinases

Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases

Arylsulfonamide derivatives as C-Jun-N-Terminal Kinases (JNK&#39;s) inhibitors

Pharmaceutically active sulfonyl amino acid derivatives

Pharmaceutically active sulfonyl hydrazide derivatives

Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or CNS disorders

Method of inhibiting the expression and/or the activity of JNK

Azole methylidene cyanide derivatives and their use as protein kinase modulators

ObsEva SA

Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof

Compositions and methods for the treatment of adenomyosis and rectovaginal endometriosis

Gonadotropin-releasing hormone antagonist dosing regimens for the treatment of endometriosis

Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof

Gonadotropin-releasing hormone antagonist dosing regimens for treating uterine fibroids and reducing menstrual blood loss

Compositions and methods for delaying the incidence of labor

MERCK SERONO SA

Pharmaceutically active sulfonyl hydrazide derivatives

Pharmaceutically active sulfonamide derivatives

Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases

Sulfonamide derivatives for the treatment of diabetes

Pyridinyl acetonitriles

Benzazole derivatives for the treatment of scleroderma

ARES TRADING SA

Benzothiazole formulations and use thereof

APPLIED RESEARCH SYSTEMS

Benzazole derivatives and their use as JNK modulators

PREGLEM SA

Method for treating gynecological diseases

Arylsulfonamide derivatives as C-Jun-N-Terminal Kinases (JNK's) inhibitors